Alternative Name(s): Benchtop F0/F2 Speech Processor
After the F-/F2 strategy had been developed in software on the laboratory computer it was necessary to realise it as a wearable device. This is shown here with control of the parameters for optimisation studies. Note also the complex wiring on the back of one of the circuit boards.
The burn in was carried out in an atmosphere of nitrogen at a temperature of 60 degrees as the chips that could fail were more likely to do so at a high temperature.
Metal square box with various buttons and dials including power and speech buttons, and volume and mute dials. Metal box is open on five sides exposing wires and circuit boards and has blue metal panel on the right hand side. There is a power cable attached to the back.
The bionic ear (also known as the cochlear implant) is the result of pioneering research commenced by Professor Graeme Clark in the late 1960s at the University of Melbourne's Department of Otolaryngology. At the time it was considered that the production of a successful cochlear implant would be extremely difficult making Government funding opportunities almost impossible. Professor Clark and his staff sought donations from the general public to originally get the project off the ground. Assistance from clubs such as Rotary, Lions and Apex was invaluable at this time.
The prototype multiple-electrode bionic ear was implanted in the first adult at The Royal Victorian Eye and Ear Hospital by Graeme Clark and colleagues in 1978. The team discovered a way to analyse complex speech signals and present it to the auditory nerve as electrical stimulation in a way that could be deciphered. They were able to engineer a speech processor small enough for a patient to wear.
As a result, the Australian Government awarded a public interest grant that helped develop the bionic ear industrially by the Australian firm Cochlear Limited. The first device for clinical trial world-wide was implanted at the Royal Victorian Eye and Ear Hospital in 1982. The international trial established that it was safe and effective and it was approved by the US Food and Drug Administration in 1985, the first multiple-electrode bionic ear to be approved by any world regulatory body.
In 1985, the team implanted the first child with a multiple-electrode bionic ear. It was developed and manufactured by Cochlear Limited in co-operation with The University of Melbourne and The Bionic Ear Institute. This was the start of a world-wide trial for the bionic ear in young children. It was approved as safe and effective for use in children born deaf or developing hearing early in life by the US Food and Drug Administration in 1990. It has also been approved by other world regulatory bodies. It is considered by many the first major advance in helping profoundly deaf children to communicate in the last 200 years since signing was established at the Paris Deaf School. The Australian Bionic Ear has now been implanted in more than 50,000 people in more than 120 countries.
Research work on the bionic ear requires collaboration between many fields. They include auditory neurobiology, auditory physiology and perception, bionics programming, psychology and neuro-engineering. In developing the bionic ear, much has been learned about nanotechnology and biotechnology including: tolerance of surgical implants by the body; interfacing electronic devices with nerves and the brain; improving speech understanding and language in deaf people; and repairing nerves. Today the knowledge of biomaterials is not only applied to hearing, but also to tackling spinal injury and epilepsy.
Graeme Clark has lodged some artefacts with the National Museum of Australia. He has also deposited material with the National Film and Sound Archive.
Transfer from University of Melbourne (The), Cochlear Pty Ltd, 12 Nov 2008
Type of item
324 mm (Width), 285 mm (Depth), 190 mm (Height)
Depth of main box unit only (not switches at front): 239mm; Length of power cord: 2 meters